Why this Raleigh pharma just cut half its workforce


A Raleigh pharmaceutical company with a late stage clinical program in its pipeline has cut about half its workforce.

Previous GE Healthcare, ICU Medical could buy Medtronic units for $8 billion
Next 81.6% of deposits here are in banks that lost $76.7B in value after SVB collapse — should you be worried?